Lucas W. Buchanan - 19 May 2023 Form 4 Insider Report for Silk Road Medical Inc

Role
COO/CFO
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
19 May 2023
Net transactions value
+$65,497
Form type
4
Filing time
31 Jul 2023, 17:44:28 UTC
Previous filing
06 Mar 2023
Next filing
15 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $13,268 +507 +0.25% $26.17 206,082 19 May 2023 Direct F1
transaction SILK Common Stock Options Exercise $12,229 +7,643 +3.7% $1.60* 213,725 28 Jul 2023 Direct
transaction SILK Common Stock Options Exercise $40,000 +2,000 +0.94% $20.00 215,725 28 Jul 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -7,643 -100% $0.000000* 0 28 Jul 2023 Common Stock 7,643 $1.60 Direct F2
transaction SILK Option (right to buy) Options Exercise $0 -2,000 -27% $0.000000 5,331 28 Jul 2023 Common Stock 2,000 $20.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
F2 All of the shares subject to the option are fully vested and exercisable as of the date hereof.